TVA Medical Lands $15,000,000 Series C Funding Round

  • Feed Type
  • Date
    10/6/2015
  • Company Name
    TVA Medical
  • Mailing Address
    7000 Bee Cave Rd. Austin, TX 78746 USA
  • Company Description
    TVA Medical, Inc. (TVA) is a medical device company developing minimally invasive therapies for End-Stage Renal Disease (ESRD).
  • Website
    http://www.tvamedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The investment round will support continuation of clinical activities and acceleration of market development for the everlinQ endoAVF System, a catheter-based technology designed to create hemodialysis access for chronic kidney disease patients in a minimally invasive procedure. Funds will support the ongoing Novel Endovascular Access Trial (NEAT) clinical study (12-month follow up to complete in 2016) and additional global clinical research, as well as device reimbursement and market access initiatives.
  • M&A Terms
  • Venture Investor
    Baxter Ventures
  • Venture Investor
    Boston Scientific Corporation
  • Venture Investor
    Sante Ventures
  • Venture Investor
    S3 Ventures
  • Venture Investor
    TriStar Technology Fund
  • Venture Investor
    Undisclosed

Trending on Xconomy